NovAliX Partners with Kyowa Hakko Kirin

News   Jan 17, 2013

 
NovAliX Partners with Kyowa Hakko Kirin
 
 
 

RELATED ARTICLES

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

Natural Product Could Lead to New Class of Commercial Herbicide

News

By looking for microorganism's protective shield, specifically the genes that can make it, a team discovered a new and potentially highly effective type of weed killer. This finding could lead to the first new class of commercial herbicides in more than 30 years.

READ MORE

Guardian of the Cell

News

Scientists unravel the structure, key features of a human immune-surveillance protein, setting the stage for more precise immune therapies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy